HTML has links - PDF has Authentication
246-945-460  <<  246-945-480 >>   246-945-485

PDFWAC 246-945-480

Facility reporting requirements.

(1) The outgoing and incoming responsible pharmacy manager must report in writing to the commission a change in a responsible manager designation within ten business days of the change.
(2) Unless otherwise specified, when permanently closing a facility, the facility must:
(a) Report to the commission in writing, no later than thirty calendar days prior to closing:
(i) The date the facility will close;
(ii) The names and addresses of the persons who shall have custody of the prescription files, bulk compounding records, repackaging records, invoices and controlled substances inventory records of the pharmacy to be closed; and
(iii) The names and addresses of any person(s) who will acquire any legend drugs from the facility to be closed, if known at the time the notification is filed.
(b) Provide notification to customers noting the last day the pharmacy will be open, name and address of the pharmacy to which prescription records will be transferred and instructions on how patients can arrange for transfer of their prescription records to a pharmacy of their choice and the last day a transfer may be initiated. Notification should include:
(i) Distribution by direct mail; or
(ii) Public notice in a newspaper of general circulation in the area served by the pharmacy; and
(iii) Posting a closing notice sign in a conspicuous place in the public area of the pharmacy.
(c) No later than fifteen days after closing:
(i) Return the facility license;
(ii) Confirm that all legend drugs were transferred or destroyed. If the legend drugs were transferred, provide the names and addresses of the person(s) to whom they were transferred;
(iii) Confirm if controlled substances were transferred, including the date of transfer, names, addresses, and a detailed inventory of the drugs transferred;
(iv) Confirm return of DEA registration and all unused DEA 222 forms to the DEA;
(v) Confirm all pharmacy labels and blank prescriptions were destroyed; and
(vi) Confirm all signs and symbols indicating the presence of the pharmacy have been removed.
(3) The commission may conduct an inspection to verify all requirements in subsection (2) of this section have been completed.
(4) The facility shall immediately report to the commission any disasters, accidents and emergencies which may affect the strength, purity, or labeling of drugs, medications, devices or other materials used in the diagnosis or the treatment of injury, illness, and disease.
(5) Any facility credentialed by the commission must report to the commission any disciplinary action, including denial, revocation, suspension, or restriction to practice by another state, federal, or foreign authority.
[Statutory Authority: RCW 18.64.005, 18.64.080, 18.130.075, 18.64.043, 18.64.044, 18.64.045, 18.64.046, 18.64.370, 18.64.460, 69.50.310, 18.64.011, 18.64.245, 18.64.470, 18.64.255, 18.64.205, 18.64.253, 18.64.410, 18.64.500, 18.64.590. WSR 20-12-072, ยง 246-945-480, filed 6/1/20, effective 7/1/20.]
Site Contents
Selected content listed in alphabetical order under each group